ES2127396T3 - Inhibidores aromaticos de acetilcolinesterasa. - Google Patents

Inhibidores aromaticos de acetilcolinesterasa.

Info

Publication number
ES2127396T3
ES2127396T3 ES94917916T ES94917916T ES2127396T3 ES 2127396 T3 ES2127396 T3 ES 2127396T3 ES 94917916 T ES94917916 T ES 94917916T ES 94917916 T ES94917916 T ES 94917916T ES 2127396 T3 ES2127396 T3 ES 2127396T3
Authority
ES
Spain
Prior art keywords
sub
independently
alkyl
acetilcolinesterasa
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94917916T
Other languages
English (en)
Inventor
Jean-Noel Collard
Jean-Marie Hornsperger
Daniel Schirlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2127396T3 publication Critical patent/ES2127396T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/361—Preparation of halogenated hydrocarbons by reactions involving a decrease in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPUESTOS DE LA FORMULA GENERAL (1), ESTEROISOMEROS Y SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, DONDE CADA Z Y Z'' SON INDEPENDIENTEMENTE H O F; Q ES (A), CH(OH), (B); X ES H, BR, CL, F O CF{SUB,3}; Y ES H, BR, CL, F, OH, OR{SUB,5}, OC(O)R{SUB,4}, N{SUB,3}, CN, NO{SUB,2}, SO{SUB,3}H, CO{SUB,2}R{SUB,4}, NH{SUB,2}, NHR{SUB,9}, NR{SUB,9}R''{SUB,9}, C(R{SUB,6})(R{SUB,7})(V''R{SUB,8}) O C(O)R{SUB,7}, SIEMPRE Y CUANDO TANTO Z COMO Z'' SEAN F, ENTONCES Y ES H O F; V Y V'' SON CADA UNA INDEPENDIENTEMENTE CH{SUB,2} O O, R{SUB,1} ES H O CH{SUB,3}; R{SUB,2}, R{SUB,9} Y R''{SUB,9} SON CADA UNO INDEPENDIENTEMENTE ALQUIL(C{SUB,1-10}), O R{SUB,2} Y V-R{SUB,3} TOMADOS JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN ADOSADOS FORMAN UN ANILLO DE 3-6 ELEMENTOS; R{SUB,3}, R{SUB,6} Y R{SUB,8} SON CADA UNO INDEPENDIENTEMENTE H, ALQUIL(C{SUB,1-6}), O CICLOALQUIL(C{SUB,3-6}); R{SUB,4} ES H, ALQUIL(C{SUB,1-10}), ARIL ALQUILENO(C{SUB,0-4}) O CICLOALQUIL(C{SUB,3-8}); Y R{SUB,5} ES ALQUIL(C{SUB,1-10}), BENCILO, FENETILO, O CICLOALQUIL(C{SUB,3-6}) , POSEE UNA ACTIVIDAD ANTICOLINAESTERASA Y PUEDE SER UTILIZADO EN EL TRATAMIENTO DE LAS DEMENCIAS DEGENERATIVAS.
ES94917916T 1993-06-04 1994-05-05 Inhibidores aromaticos de acetilcolinesterasa. Expired - Lifetime ES2127396T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93401431A EP0627400A1 (en) 1993-06-04 1993-06-04 Aromatic acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
ES2127396T3 true ES2127396T3 (es) 1999-04-16

Family

ID=8214719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94917916T Expired - Lifetime ES2127396T3 (es) 1993-06-04 1994-05-05 Inhibidores aromaticos de acetilcolinesterasa.

Country Status (19)

Country Link
US (1) US5663448A (es)
EP (2) EP0627400A1 (es)
JP (1) JP3735372B2 (es)
KR (1) KR960702820A (es)
CN (1) CN1124953A (es)
AT (1) ATE174895T1 (es)
AU (1) AU676578B2 (es)
CA (1) CA2164303C (es)
DE (1) DE69415522T2 (es)
DK (1) DK0701546T3 (es)
ES (1) ES2127396T3 (es)
FI (1) FI955795A7 (es)
HU (1) HUT73484A (es)
IL (1) IL109863A (es)
NO (1) NO306058B1 (es)
NZ (1) NZ267221A (es)
TW (1) TW385247B (es)
WO (1) WO1994029255A1 (es)
ZA (1) ZA943787B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5872101A (en) * 1995-01-06 1999-02-16 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
EP2425845A1 (en) * 2004-12-23 2012-03-07 Voyager Pharmaceutical Corporation Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
US20060194723A1 (en) * 2005-02-28 2006-08-31 Rabinoff Michael D Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
BR112012008346B1 (pt) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
EP2533645B1 (en) * 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
CN102826985B (zh) * 2012-09-18 2015-08-19 厦门大学 一种1-(3,4,5-三羟基)苯基-1-烷基酮的制备方法
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
MX384391B (es) 2015-05-22 2025-03-14 Agenebio Inc Composiciones farmacéuticas de levetiracetam de liberación extendida.
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU884568A3 (ru) * 1977-10-07 1981-11-23 Сьянс Юньон Э Ко.,Сосьете Франсэз Де Решерш Медикаль(Фирма) Способ получени (арилалкил) алкановых кислот
US4835099A (en) * 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis
DE3725941A1 (de) * 1987-08-05 1989-02-16 Hoechst Ag Ester von arylperfluoralkylcarbinolen, verfahren zur herstellung dieser verbindungen und der zugrundeliegenden arylbisperfluoralkylcarbinole
JP2509282B2 (ja) * 1987-09-24 1996-06-19 鹿島石油株式会社 光学活性なジフルオロアルコ―ル誘導体
NZ231735A (en) * 1988-12-23 1992-04-28 Ici Plc Alcohol/ether derivatives, preparation and pharmaceutical compositions thereof
US5214069A (en) * 1988-12-23 1993-05-25 Imperial Chemical Industries Plc Alcohol and ether derivatives
JPH02200646A (ja) * 1989-01-31 1990-08-08 Nippon Oil & Fats Co Ltd フルオロアルキル基含有芳香族誘導体及びその製造方法
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors
DE3927049A1 (de) * 1989-08-16 1991-02-21 Sandoz Ag Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung
EP0611769A1 (en) * 1993-02-16 1994-08-24 Merrell Dow Pharmaceuticals Inc. Silylated acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
CN1124953A (zh) 1996-06-19
KR960702820A (ko) 1996-05-23
FI955795A0 (fi) 1995-12-01
ATE174895T1 (de) 1999-01-15
JP3735372B2 (ja) 2006-01-18
IL109863A0 (en) 1994-10-07
DE69415522D1 (de) 1999-02-04
FI955795A7 (fi) 1995-12-01
EP0701546B1 (en) 1998-12-23
NO954896L (no) 1996-02-02
JPH08511019A (ja) 1996-11-19
EP0701546A1 (en) 1996-03-20
CA2164303C (en) 2000-11-28
IL109863A (en) 1998-12-27
CA2164303A1 (en) 1994-12-22
DE69415522T2 (de) 1999-06-02
AU6944294A (en) 1995-01-03
TW385247B (en) 2000-03-21
NO306058B1 (no) 1999-09-13
EP0627400A1 (en) 1994-12-07
AU676578B2 (en) 1997-03-13
ZA943787B (en) 1995-01-30
HUT73484A (en) 1996-08-28
US5663448A (en) 1997-09-02
WO1994029255A1 (en) 1994-12-22
DK0701546T3 (da) 1999-08-16
HU9503452D0 (en) 1996-01-29
NZ267221A (en) 1997-11-24
NO954896D0 (no) 1995-12-01

Similar Documents

Publication Publication Date Title
ES2127396T3 (es) Inhibidores aromaticos de acetilcolinesterasa.
DK0577847T3 (da) Morphinanderivat og medicinsk anvendelse deraf
CO4410321A1 (es) Compuestos ciclicos condensados con funciones aminoacidas sustituidas y derivados ester de los mismos
NL971014I2 (nl) Heterocyclische verbindingen.
ES2181902T3 (es) Derivados de 4,5-diaril-oxazol.
ATE21894T1 (de) Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln.
CA2066640A1 (en) Heterocyclic compounds
MX9300988A (es) Agentes antineoplasticos de quinobenzoxazina, quinobenzotiazina y pirido-acridina y composicion farmaceutica que los contiene.
EA199700346A1 (ru) Диазепино-индоловые ингибиторы фосфодиэстераз iv
ZA8410038B (en) 1,3,4,5-tetrahydrobenz(c,d,)indoles,a process for their preparation and their use
ATE26263T1 (de) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine, verfahren zur herstellung derselben und ihre verwendung als heilmittel.
ATE250060T1 (de) O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen
MY131381A (en) Piperazine derivatives suitable for use as pharmaceuticals, in particular as 5-ht1a receptor binding agents.
ES8502988A1 (es) Procedimiento para preparar derivados de piperacina.
SE8203877D0 (sv) Aminosulfonylbensoesyraderivat
DE3764077D1 (de) Zentralwirkende muskelrelaxante.
ES2104688T3 (es) Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido.
HUP9702227A2 (hu) Új benzopiránvegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
NO904067L (no) Fremgangsmaate for kjemisk opploesning av 5-alkoksy-substituert (+)-1,3-dimethyloxindolylethylaminer.
ATE36705T1 (de) Arzneimittel auf basis von piperidinderivaten, piperidinderivate und verfahren zu ihrer herstellung.
DE69201848D1 (de) Verfahren zum Härten von Gelatine.
DK0900082T3 (da) Anvendelse af pyridyl- og pyrimidyl-piperaziner til fremstilling af et lægemiddel til behandling af rusgiftbetingede lidelser
ES2052825T3 (es) Derivados de cicloalquiltiazol.
SE429864B (sv) Forfarande for framstellning av 1-(3-fenyl-propyl-4-furoylpiperaziner

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701546

Country of ref document: ES